Sensei Biotherapeutics Inc. (NASDAQ: SNSE)
$0.70
-0.0175 ( -2.44% ) 40.9K
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Market Data
Open
$0.70
Previous close
$0.72
Volume
40.9K
Market cap
$18.06M
Day range
$0.70 - $0.74
52 week range
$0.51 - $1.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 65 | Jun 03, 2024 |
8-k | 8K-related | 15 | May 23, 2024 |
3 | Insider transactions | 2 | May 16, 2024 |
10-q | Quarterly Reports | 74 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
8-k | 8K-related | 14 | Apr 12, 2024 |
8-k | 8K-related | 13 | Apr 02, 2024 |